B6N.Cg-Mirc12tm1.1Doca/Cnrm

Status

Available to order

EMMA IDEM:05331
International strain nameB6N.Cg-Mirc12tm1.1Doca/Cnrm
Alternative nameMiR-144/451
Strain typeTargeted Mutant Strains : Knock-in
Allele/Transgene symbolMirc12tm1.1Doca,
Gene/Transgene symbolMirc12

Information from provider

ProviderDónal O
Provider affiliationMouse Biology Unit, European Molecular Biology Laboratory
Genetic informationAn enhanced GFP (eGFP) expression cassette with a 3'- FRT flanked neor cassette was inserted into the miR-144/451 locus. Flp mediated recombination removed the neor cassette. The presence of the eGFP cassette disrupts expression of miR-144 and miR-451 and allows tracing of transcriptional activity from the miR-144/451 locus.
Phenotypic informationHomozygous mice carrying the miR-144/451-EGFP-KI allele display an impairment of late erythroblast maturation, resulting in erythroid hyperplasia, splenomegaly, and a mild anemia.
Breeding historyUpon germ line transmission, the mice carrying the targeted allele were crossed to FLP-expressing transgenic mice (FLPeR) to remove the frt flanked neor cassette. The resulting mice were then backcrossed to C57BL/6N to remove the FLP transgene. The offspring carrying the mutation were backcrossed 5 generations to C57BL/6N.
References
  • The miR-144/451 locus is required for erythroid homeostasis.;Rasmussen Kasper D, Simmini Salvatore, Abreu-Goodger Cei, Bartonicek Nenad, Di Giacomo Monica, Bilbao-Cortes Daniel, Horos Rastislav, Von Lindern Marieke, Enright Anton J, O'Carroll Dónal, ;2010;The Journal of experimental medicine;207;1351-8; 20513743
Homozygous fertileyes
Homozygous viableyes
Homozygous matings requiredno
Immunocompromisedno

Information from EMMA

Archiving centreCNR, Consiglio Nazionale delle Ricerche, Monterotondo, Italy

Disease and phenotype information

MGI phenotypes (allele matching)
  • abnormal proerythroblast morphology / MGI
  • hematopoietic system phenotype / MGI
  • increased erythroblast number / MGI

Literature references

  • The miR-144/451 locus is required for erythroid homeostasis.;Rasmussen Kasper D, Simmini Salvatore, Abreu-Goodger Cei, Bartonicek Nenad, Di Giacomo Monica, Bilbao-Cortes Daniel, Horos Rastislav, Von Lindern Marieke, Enright Anton J, O'Carroll Dónal, ;2010;The Journal of experimental medicine;207;1351-8; 20513743

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen embryos. Delivered in 4 weeks (after paperwork in place). €1740*
  • Rederivation of mice from frozen stock, delivery time available upon request . €3880*

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
For this strain no provider MTA is needed. Distribution is based on the EMMA conditions only.

EMMA conditions
Legally binding conditions for the transfer

Other EMMA strains

Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).